Verapamil Hydrochloride

ANDA 75072, held by Strides Pharma Intl. Verapamil Hydrochloride.

As of Nov 15, 2026, ANDA 75072 (Verapamil Hydrochloride), held by Strides Pharma Intl, was first approved by FDA on May 25, 1999, with 6 approved supplements and 0 published complete response letters.

First approved: May 25, 1999
Supplements approved: 6
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 7 submissions below

Date	Submission	Status	Documents
May 25, 1999	Original application	Approved	Letter Label Review

Products

2 strengths and forms


Verapamil Hydrochloride120MG · tablet, extended release;oral	Verapamil Hydrochloride	Rx
Verapamil Hydrochloride240MG · tablet, extended release;oral	Verapamil Hydrochloride	Rx

All 7 submissions, including labeling and manufacturing supplements


May 20, 2002	Supplement 6Manufacturing	Approved	None posted
May 20, 2002	Supplement 5Manufacturing	Approved	None posted
Mar 22, 2002	Supplement 4Manufacturing	Approved	None posted
Aug 21, 2001	Supplement 3Labeling	Approved	None posted
Feb 14, 2001	Supplement 2Labeling	Approved	None posted
Jun 24, 1999	Supplement 1Manufacturing	Approved	None posted
May 25, 1999	Original application	Approved	Letter Label Review

Identifiers

Application: ANDA 75072
Drugs@FDA: Overview at FDA
Company: Strides Pharma International

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters